Relationship between Vitamin D Status, Dyslipaedemia and Antioxidant Status in Children with Idiopathic Nephrotic Syndrome in South West, Nigeria
Asian Journal of Chemical Sciences,
Dysregulated lipid metabolism and oxidative stress are strong factors that are implicated in the development of proteinuria and glomerular injury in Nephrotic Syndrome (NS). Vitamin D seems to be a promising tool in influencing lipid metabolism and antioxidant status in NS.
Aim: This study aims at investigating the relationship between Vitamin D, dyslipaedemia and oxidative stress in NS.
Study Design: This is a case-control study.
Place and Duration of Study: Children’s Outpatient Clinic (CHOP) of University College Hospital (UCH) Ibadan, Nigeria between year 2019-2021.
Methods: This study involves fifty children aged 5 to 12 years, freshly diagnosed with Idiopathic NS and fifty apparently healthy children as control. Blood samples were taken from them and analytes quantified by standard laboratory methods. Students’ t test and Pearson correlation were used to compare variables between the two groups respectively.
Results: Results showed significant decrease (P <.001) in Vit. D levels, GPX, SOD and CAT in NS. A significant decrease (P<.001) occurred in HDL, a significant increase (P <.001) in TG, TC and LDL levels in children with NS when compared with the control. There was a strong significant positive relationship between Catalase and Vit. D, SOD and Vit. D (r= 0.896, 0.869 respectively, P<.001) in NS. While a weak non significant positive relationship occurred between HDL and Vit. D, GPX and Vit D (r=0.0585, 0.0236 respectively, P >.001). A weak negative relationship occurred between TG and Vit. D, TC and Vit. D, LDL and Vit. D (r=-0.0432,-0.219, -0.231 respectively, P>.001), in NS. Thus, vitamin D insufficiency influences serum lipid profiles and antioxidants in paediatric Idiopathic NS.
- Idiopathic nephrotic syndrome
- glomerular injury
- lipid profile
How to Cite
Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the international study of kidney disease in children. Kidney Int1978;13:159–165.
Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet.2003;362 (9384):629–39.
Lombel RM, Gipson DS, Hodson EM . “Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO,” Paediatric Nephrology.2013; 28(3): 415–426.
Trygvason K, Patrakka J, Wartiorova J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med.2006;354 :1387– 1401
Damien GN, Kazumoto I, Rulan P.Idiopathic nephrotic syndrome in children. The Lancet.2007; 392:10141.
Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin. J. Am. Soc. Nephrol.2012; 7(3): 513–520
Nelson RH. Hyperlipidaemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195-211.
Jackson SP, Calkin AC. The clot thickens — oxidized lipids and thrombosis. Nat Med. 2007;13:1015–1016.
Sacks FM, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–1009.
Halliwell B. Free Radicals, Antioxidants, and Human Disease—Curiosity, Cause, or Consequence. Lancet. 1999; 344 (8924): 721-724.
Kaneko K, Kimata T, Takahashi M, Shimo T, Tanaka S, Tsuji S. Change in urinary 8-hydroxydeoxyguanosine in idiopathic nephrotic syndrome. Pediatr Nephrol.2011. doi:10.1007/s00467-011-2031-6
Mishra OP, Gupta AK, Prasad R, Ali Z, Upadhyay RS, Mishra SP, Tiwary NK, Schaefer FS. Antioxidant status of children with idiopathic nephrotic syndrome. Pediatr Nephrol.2011;26(2):251–256
Fydryk J, Jacobson E, Kurzawska O, Małecka G, Gonet B, Urasiński T, Brodkiewicz A, Bukowska H .Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol .1998;12(9):751–754
De Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS, “25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification,” Journal of the American Society of Nephrology.2009; 20(8):1805–1812.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition.2000; 72( 3): 690–693,
Ayobola Abimbola Sonuga, Oyebola Oluwagbemiga Sonuga. Hypovitaminosis D is associated with some Metabolic Indices in Gestational Diabetes Mellitus. Biomedicine Hub.2020;5: 508207
Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49( 5): 1063–1069.
Sonuga AA, Asaolu MF, Oyeyemi AO, Sonuga OO. Effects of Vitamin D3 supplementation on Antioxidant status and Lipid Peroxidation Product in Preeclamptic Women. Open Access Journal Gynecol. 2019, 4(1)9-16.
Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R, “Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study,” International Journal of Epidemiology.1990; 19(3):559–563.
Poole KES, Loveridge N, Barker PJ et al. Reduced vitamin D in acute stroke. Stroke. 2006; 37(1), pp. 243–245, 2006.
Holick MF.Vitamin D deficiency.2007; N Engl J Med;357:266-81.
Trinder, P. Enzymatic calorimetric determination of triglycerides by GOP-PAP method. Ann. ClinBiochem. 1969; 6: 24- 27.
Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem.1977; 23, 882-884.
Trinder P. Report of the national Cholesterol Educational Program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch. Intern. Med.1988; 148:36- 39.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem.1972; 18: 499-502.
Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R . A novel biologically active seleno-organic compound- II, activity of PZ 51 in relation to glutathione peroxidase, Biochemical Pharmacology 1984;33(7): 3241- 3245.
Kuthan H, Haussmann HJ, Werringloer J. A spectrophotometric assay for superoxide dismutase activities in crude tissue fraction. Biochemical Journal 237(1): 175-180.
Sinha AK. Colorimetric Assay of Catalase. Analytical Biochemistry.1972; 47(2): 389-394.
Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635–642.
Floege J. Introduction to glomerular disease: clinical presentations. In: Johnson RJ, Feehally J, Floege J, eds. Comprehensive Clinical Nephrology. 5th ed. Philadelphia, Pa.: Elsevier Saunders; 2015.
Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336 (7654):1185–1189.
Humphreys MH. Mechanisms and management of nephrotic edema. Kidney Int. 1994;45(1):266–81.
Hussein HA, DE Sallam, Soliman DA, Ghoneimy DH, Amr NH, El-Hakim IZ, Vitamin D status in children with idiopathic nephrotic syndrome, QJM: An International Journal of Medicine, Volume 111, Issue suppl_1,
Selewski, David T et al. “Vitamin D in incident nephrotic syndrome: a Midwest Paediatric Nephrology Consortium study.” Paediatric nephrology. 2016;31(3): 465- 72.
Lambert PW, De Oreo PB, Fu IY, Kaetzel DM, von Ahn K, Hollis BW, Roos BA. Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. Metab Bone Dis Relat Res. 1982;4:7–15.
Dickson LE, Wagner MC, Sandoval RM, Molitoris BA. The proximal tubule and albuminuria: really! J Am Soc Nephrol. 2014;25:443–453.
Goldstein DA, Oda Y, Kurokawa K, Massry SG. Blood levels of 25-hydroxy vitamin D in nephrotic syndrome. Studies in 26 patients. Ann Intern Med. 1977;87:664–667.
Diamond JR The role of reactive oxygen species in animal model of glomerular disease. Am J Kidney Dis. 1992; 19: 292–300
Delvin EE, Merouani A, Levy E 2003 Dyslipidemia in paediatric nephrotic syndrome: causes revisited. Clin Biochem. 36; 95–101
De Sain-van der Velden MG, et al. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int. 1998;53:994–1001.
Kaysen GA, Mehendru L, Pan XM, Staprans I. Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis. Am J Physiol .1992; 263: F335–F341,
Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis. N Engl J Med. 1990 Aug 30; 323(9):579-84
Zachwieja J, Bobkowski W, Dobrowolska ZA, Zaniew M, Maciejewski J. Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome. Medical Science Monitor.2003; 9(6):235–239.
Mader-WI and Zwoli D.Peroxidation of lipids ´ and activity of antioxidant enzymes in children with nephrotic syndrome. Polski Merkuriusz Lekarski. 2001;10 (58):233– 236, 2001.
Ece A, Atamer Y, Gurkan F, Bilici M, Kocyigit Y 2004 Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephritic syndrome. Nephrology 9: 366–373
Warwick GL, Waller H , Ferns GAA. Antioxidant vitamin concentrations and LDL oxidation in nephrotic syndrome. Ann Clin Biochem. 2000; 37: 488-491
Jyoti D, Purnima D, Sarkar J .Study of oxidative stress, homocysteine, copper & zinc in nephrotic syndrome: therapy with antioxidants, minerals and B-complex vitamins. Biochem Tech. 2009; 1(4):104-107.
Berridge M.J. Vitamin D deficiency accelerates ageing and age-related diseases: A novel hypothesis. J. Physiol. 2017;595 :6825–6836.
Kovesdy CP, Ahmadzadeh S, Anderson JE, KalantarZadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med. 2008;168:397-403. 78. Finch JL, Suarez EB,
Nakai K, Fujii H, Kono K, Goto S, Kitazawa R, Kitazawa S, et al. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am J Hypertens. 2014;27:586-95
Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005;7:385-94
Jiang X, Peng M, Chen S, Wu S, Zhang W. Vitamin D deficiency is associated with dyslipaedemia: a cross-sectional study in 3788 subjects. Curr Med Res Opin. 2019 Jun;35(6):1059-1063.
Karnchanasorn R, Ou H, Chiu K. Plasma 25-hydroxyvitamin D levels are favorably associated with β-cell function. Pancreas. 2012;41(6):863–8.
Christakos S, Dhawan P, Porta A, et al. Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol. 2011;347(1-2):25–9.
Abstract View: 54 times
PDF Download: 24 times